Precision Injection Molding Solution for CGM Blood Glucose Meter Components Using Micro-liquid Silicone Overmolding Technology
Leave a message
Introduction
In today's rapidly developing medical technology landscape, continuous glucose monitoring (CGM) systems have become essential tools in diabetes management. As a key process in CGM device manufacturing, micro-liquid silicone encapsulation technology is driving the entire industry towards greater precision, reliability, and user-friendliness. This article systematically elucidates the innovative applications and development trends of this cutting-edge technology in the manufacturing of blood glucose meter components.
Technical Challenges
As CGM devices increasingly move towards miniaturization and intelligence, manufacturing processes face multiple challenges:
First, balancing miniaturization and performance: While device size continues to shrink, the demands for functionality and reliability are constantly increasing, posing significant challenges to manufacturing processes.
Second, regarding biocompatibility: Since the devices need to be in prolonged contact with the human body, materials must possess both excellent biocompatibility and comfort to ensure a superior user experience.
Third, precise sealing is crucial; sensors must maintain high reliability and monitoring accuracy under complex operating environments.
Finally, consistency in large-scale production is another key challenge, requiring stable mass production while meeting medical-grade quality requirements.
Technological Breakthrough: Precision Injection Molding with Micro-volume Liquid Silicone Overmolding
Material Innovation Breakthrough
We utilize advanced medical-grade liquid silicone materials, which possess the following outstanding characteristics: biocompatibility certified, excellent tactile feel and durability, and stability within a temperature range of -60℃ to 250℃.
Process Technology Innovation
Addressing the trend towards miniaturization in continuous glucose monitoring (CGM) devices (approximately 2.0 grams), our developed liquid silicone overmolding technology enables precise molding of ultra-thin, complex structures, fully meeting the stringent requirements of high-precision sensor encapsulation. Through advanced injection molding processes, we achieve one-step molding of high-precision, complex overmolded components, effectively supporting the miniaturization and precision requirements of sensors.
Automated Production System
The CGM production line employs a fully automated injection molding process, equipped with an automated testing system, enabling large-scale, high-efficiency production. This highly automated production method not only ensures product consistency but also increases production efficiency by 40%, achieving a product yield of over 98%.
Future Development Trends
Integrated Design
With the advancement of closed-loop insulin pump system research and development, liquid silicone encapsulation technology will be further applied to the integration of CGM (Continuous Glucose Meter) and insulin delivery modules, achieving a more compact, integrated medical device design.
Cost Reduction Path
Through continuous optimization of injection molding processes, including the use of multi-cavity molds and rapid vulcanization technologies, the manufacturing cost of continuous glucose monitoring (CGM) meters is expected to be significantly reduced, promoting the widespread application of this technology.
The application of liquid silicone encapsulation technology in CGM blood glucose meter sensors not only significantly improves sensor performance and reliability but also greatly enhances patient comfort and user experience, which is of great significance for promoting the further development of CGM technology.
Conclusion
Liquid silicone encapsulation technology is becoming one of the key technologies in the field of high-end medical device manufacturing. Suzhou Donghao Precision Manufacturing Co., Ltd. provides reliable precision manufacturing solutions for global medical device manufacturers through continuous technological innovation.








